Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for March 2009
March 2, 2009
- ZymoGenetics Collaboration with Bristol-Myers Squibb Clears Review Under Hart-Scott-Rodino Antitrust Improvements Act
- Obama Expected to Nominate Sebelius Health Secretary
- Lilly Announces Leadership Changes
- United States Files Suit Against Missouri-Based Pharmaceutical to Block Manufacturing and Shipping of Unapproved Drugs
March 3, 2009
- Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo
- Bayer: Corporate Strategy Proves Effective in a Difficult Environment
- Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions
- Epsilon Study Shows 'Healthy' Response to Email from Pharma Companies
- FDA Warning Letter to Genzyme Related to the Allston Manufacturing Facility
- Bristol-Myers Squibb Announces Organizational Changes; Names Four to Company's Executive Committee
March 4, 2009
- Bristol-Myers Squibb Names Andreotti President and Chief Operating Officer
- Acusphere Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
- Combined Use of Antiplatelet, Gastric Acid Medications Following Heart Attack or Angina Associated With Increased Risk of Death, Hospitalization
- US Food and Drug Administration Stresses Science-Based Compliance and Open Lines of Communication for 2009
- Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
- Astellas Terminates Agreement on Antipsychotic Agent ASP2314/ACR-16
March 5, 2009
- Bradmer Implements Cash Conservation Plan
- Sens. Dorgan, Snowe, Mccain, Stabenow Introduce Bipartisan Prescription Drug Imporation Bill
- Sen. Grassley: It should be legal to buy prescription drugs from other countries
- NICE Refuses Funding for Advanced Breast Cancer Treatment, Tyverb (lapatinib)
- CVS Caremark May be Violating Privacy of Hundreds of Thousands of Floridians, According to CtW
March 6, 2009
- Apex Bioventures Acquisition Corp. To Seek Stockholder Approval To Liquidate and Dissolve
- Astellas to Nominate Two Directors and Submit Proposal to Remove Remaining Four Directors of CV Therapeutics
- OPKO Health Announces Update on Phase III Clinical Trial of Bevasiranib
- FDA Sends Gilead Letter Over Statements Made By Gilead Representative
- Genentech Urges Shareholders to Take No Action With Respect to Revised Offer From Roche
- Roche Increases Offer Price for Genentech Shares to US$ 93 Per Share and Extends Offer
March 9, 2009
- Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
- Merck and Schering-Plough to Merge
- Consumer Watchdog: Health Insurers & Drug Companies Contributed $5.5 Million to Top 10 Senate and House Recipients Since 2005
- IDM Pharma's Mepact (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
- Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
March 10, 2009
- Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
- CytoDyn Responds to FDA as High Court Rules Agency Cannot Guarantee Drug Safety
- Nurse Practitioners Don't Realize How Much Their Prescribing is Being Influenced By Drug Marketing
- FDA Sends Genzyme Letter Over Conditions at Massachusetts Plant
- R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
March 11, 2009
March 12, 2009
- Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
- Pharmaceutical & Medical Packaging News Magazine Launches Online Supplier Video Resource For Packaging Industry
- Bipartisan Group of Members Introduces “Promoting Innovation and Access to Life-Saving Medicines Act”
- Gilead Sciences Agrees to Acquire CV Therapeutics for $20.00 Per Share
- EPIX Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results
- Table Reservations Open to Healthcare Advertising Agencies for the 20th Annual Med Ad News Manny Awards
- CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer
March 13, 2009
- Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M.
- Approval of Clevudine for the Treatment of Chronic Hepatitis B in the Philippines
- Synta Restructures Organization to Focus on New Priorities
- Patrick Administration Passes Tough New Rules Governing Pharmaceutical and Medical Device Industries
- New FDA Heads Must Resist Fear
March 16, 2009
- Astellas to Terminate Offer for CV Therapeutics
- WEEKLY ADDRESS: President Barack Obama Announces Key FDA Appointments and Tougher Food Safety Measures
- Med Ad News Launches Online Forum Connecting Pharmaceutical Professionals With Industry Experts
- Roche Acquires Innovatis AG to Complement Its Product Portfolio in the Rapidly Growing Area of Cellular Analytics
- Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
March 17, 2009
- Consumer Reports Poll: 66% of Americans Blindsided by Cost of Drugs; Many Not Taking Needed Medications
- Med Ad News Magazine Announces Nominees for the 20th Annual Manny Awards as Well as Advertising Person of the Year
- Cytos Biotechnology Announces Alignment of Resources Following Setback in the Development of its Hypertension Vaccine CYT006-AngQb
- EBE Calls for Urgent Action
- New Type of Botulinum Toxin Appears to Be Well Tolerated and May Help Reduce Forehead Wrinkles
March 18, 2009
- Statement by Teva Pharmaceuticals on Eshoo-Barton Bill
- Schering-Plough Europe Withdraws Its Marketing Authorisation Application For Cylatron (peginterferon alfa-2b)
- Merck Statement on New Jersey Court Ruling Denying Certification of Class of Plaintiffs Seeking Reimbursement for Out-of-Pocket Vioxx Costs
- PharmaLive.com Launches New Drugs Outlook Report
- Reps. Eshoo, Inslee, and Barton Introduce Pathway for Biosimilars Act
- Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
March 19, 2009
- Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
- Teva and Medicis Announce Settlement Agreement
- FDA Advisory Committee Recommends Approval of Multaq (dronedarone)
- Ex-Pfizer Manager Found Guilty of Obstruction
- IMS Health Reports U.S. Prescription Sales Grew 1.3 Percent in 2008 to $291 Billion
March 20, 2009
- Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
- Shire Files Lawsuit Against Mylan for Infringement of Fosrenol (Lanthanum Carbonate) Patent
- Forest Laboratories, Inc. Announces FDA Approval of Lexapro for the Treatment of Major Depressive Disorder in Adolescents
- Adventrx Announces Further Cost-Cutting Measures
March 23, 2009
March 24, 2009
- Hospira Announces Plans to Optimize Operations, Increase Shareholder Value
- Merck & Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to Vioxx
- GSK Publishes 2008 Corporate Responsibility Report
- Fablyn Approved in Europe for the Treatment of Osteoporosis
March 25, 2009
- Sen. Grassley Calls on FDA Leader to Clarify Employees’ Right to Speak Up About Agency Matters
- Pfizer Announces Completion of $13.5 Billion Debt Offering
- The American Psychiatric Association Phases Out Industry-Supported Symposia
March 26, 2009
- Roche Completes Tender Offer for Genentech
- Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company
- Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation
- New Report Finds FDA is Overfunded, Overstaffed, and Costs Lives
- CVS Caremark's Objectionable Drug Marketing Practices Raised at Massachusetts Joint Committee on Health Care Financing Hearing Today, According to CtW
March 27, 2009
- Akela and Nventa Announce Merger
- Evotec AG (DE) - Evotec Restructures and Implements "Evotec 2012 - Action Plan to Focus and Grow"
- InSite Vision Announces Restructuring to Support 2009 Strategic Priorities
- Osiris Discontinues Enrollment in Crohn's Study Due to Concerns with Trial Design
- Senators Announce Bipartisan Proposal To Bring Generic Biologic Drugs To Market, Saving Billions In Medicare Costs
- Takeda Establishes Presence in Canada
- IMS, SDI Seek U.S. Supreme Court Review in Critical First Amendment Case
- Regional Biotech Association Warns Vermont Legislation Could Have Profound Negative Impact
March 30, 2009
- Adherex Reports 2008 Fiscal Results
- Takeda Expands its Own Sales and Marketing Operations in Europe
- EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts
March 31, 2009
- Genzyme and Bayer HealthCare Enter New Strategic Agreement
- Shire and GlaxoSmithKline Enter Agreement to Co-promote Vyvanse (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
- Dyax to Focus Resources on DX-88 Commercial Launch with Reduction in Force
- Takeda to Create Global Centers of Excellence
- Cardinal Health to Reduce Workforce to Respond to Economic Conditions
- FDA Advisory Committee Unanimously Recommends Accelerated Approval of Avastin for Previously Treated Brain Cancer (Glioblastoma)
- Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta and Declares Patent Invalid
- Cialis, Cymbalta Lead 2008’s Most Recalled Drug Ads
